Search hospitals > Massachusetts > Boston
Fenway Community Health
Claim this profileBoston, Massachusetts 02215
Global Leader in Antiretroviral Therapy
Global Leader in Human Immunodeficiency Virus Infection
Conducts research for HIV/AIDS
Conducts research for AIDS
Conducts research for Infections and Infestations
92 reported clinical trials
7 medical researchers
Summary
Fenway Community Health is a medical facility located in Boston, Massachusetts. This center is recognized for care of Antiretroviral Therapy, Human Immunodeficiency Virus Infection, HIV/AIDS, AIDS, Infections and Infestations and other specialties. Fenway Community Health is involved with conducting 92 clinical trials across 76 conditions. There are 7 research doctors associated with this hospital, such as Kenneth Mayer, MD, Ken Mayer, MD, Peter R Chai, MD, MMS, and Conall O'Cleirigh, PhD.Top PIs
Kenneth Mayer, MDFenway Health1 year of reported clinical research
Studies HIV/AIDS
Studies Medication Adherence
3 reported clinical trials
7 drugs studied
Ken Mayer, MDFenway Health Institute1 year of reported clinical research
Studies Compliance
Studies Antiretroviral Therapy
3 reported clinical trials
5 drugs studied
Peter R Chai, MD, MMSFenway Health6 years of reported clinical research
Studies Substance Addiction
Studies Human Immunodeficiency Virus Infection
3 reported clinical trials
8 drugs studied
Conall O'Cleirigh, PhDFenway Community Health5 years of reported clinical research
Studies Nicotine Addiction
Studies Depression Treatment
3 reported clinical trials
5 drugs studied
Clinical Trials running at Fenway Community Health
Substance Addiction
HIV (Human Immunodeficiency Virus)
Substance Use Disorder
Addiction
Human Immunodeficiency Virus Infection
Medication Adherence
Treatment Compliance
Pre-Exposure Prophylaxis
Antiretroviral Therapy
HIV/AIDS
SmartSteps Intervention
for HIV Prevention
This is a single-arm, observational study of HIV-negative MSM with substance use disorder. Those who meet pre-screening criteria will attend a Screening Visit (Visit 1), where the informed consent process will be conducted and study eligibility will be confirmed. Eligible participants will attend three additional visits over the course of the study - the Enrollment Visit (Visit 2), Month 1 Visit (Visit 3), and Month 2 Visit (Visit 4). Participants will take one PrEP digital pill per day, for 60 days total, while using the digital pill system (DPS) and Beiwe, a digital phenotyping app. On nonadherent days, participants will receive brief surveys prompting them to report the reasons for their missed dose, as well as their engagement in substance use and sexual activity. Timeline followback will be conducted at the Month 1 and Month 2 Visits to understand the context of any nonadherence. Qualitative user experience exit interviews and dried blood spots (DBS) will be conducted at the Month 2 Visit.
Recruiting2 awards Phase 38 criteria
Text-Based Intervention
for HIV and Substance Use Disorders
Men who have sex with men (MSM), and gender minority individuals who have sex with men, living with HIV and substance use disorders (SUDs) are less likely to be virally suppressed, which can lead to HIV transmission and negative health outcomes. This hybrid type 1 study will assess the efficacy, mechanisms, as well as facilitators and barriers to implementing the MATTER intervention, a virtually delivered 5-session text-enhanced psychobehavioral intervention designed to facilitate viral suppression by addressing internalized stigma and shame as barriers to engagement in HIV care among MSM and gender minority individuals living with HIV and SUDs in two locations with different levels of HIV resources (i.e., the Boston, Massachusetts and Miami, Florida metro areas). MATTER aims to mitigate the negative behavioral consequences of internalized stigma and shame on viral suppression by a) developing behavioral self-care goal setting skills and related self-efficacy, b) increasing metacognitive awareness (i.e., non-judgmental awareness of emotions and cognitions), and c) teaching and reinforcing compassionate self-restructuring (i.e., self- compassion), in addition to providing access to phone-based resource navigation. Scalable interventions such as MATTER are essential to our efforts to end the HIV epidemic in high priority regions.
Recruiting1 award N/A11 criteria
Emotion Regulation Program
for HIV+ Individuals with Substance Use Disorder
This study will implement a pilot randomized controlled trial (RCT, N=70) to refine and assess the feasibility and acceptability of an emotion regulation and communication skills intervention designed to improve engagement in HIV-care among substance using HIV+ PWID sub-optimally engaged in HIV care.
Recruiting1 award N/A
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Fenway Community Health?
Fenway Community Health is a medical facility located in Boston, Massachusetts. This center is recognized for care of Antiretroviral Therapy, Human Immunodeficiency Virus Infection, HIV/AIDS, AIDS, Infections and Infestations and other specialties. Fenway Community Health is involved with conducting 92 clinical trials across 76 conditions. There are 7 research doctors associated with this hospital, such as Kenneth Mayer, MD, Ken Mayer, MD, Peter R Chai, MD, MMS, and Conall O'Cleirigh, PhD.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.